×
返回 Agenda
Session 10 (Parallel Session) : CMC and Non-Clinical
Session Chair(s)
Dong Hee Na, PhD
Professor
Chung-Ang University, Korea, Republic of
In-sook Park, PhD
Director General
Korean Regulatory Science Center, Korea, Republic of
Speaker(s)
Thomas Steger-Hartmann, PhD
Bayer Pharma AG, Germany
Senior Project Lead Innovative Health Initiative, VP
Sukmo Kang, DVM, PhD
BIOTOXTECH, BTT Group, Korea, Republic of
Director, Business Development / Research Planning
Jaewoon Son, PhD
GC BioPharma, Korea, Republic of
MSAT/DP Team Leader
Ohseok Kwon, PhD
Ministry of Food and Drug Safety, Korea, Republic of
Recombinant Protein Products Division
Young Joo Park, PhD, MPH
DIA, Korea, Republic of
VP, Korea, Singapore, and Southeast Asia